Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cancer

NCT07616258 is registered in ClinicalTrials.gov with Royal College of Surgeons, Ireland as lead sponsor.

NCT NCT07616258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07616258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cancer
Lead sponsor
Royal College of Surgeons, Ireland
Phase
Not applicable
Overall status
Recruiting
Start date
October 2, 2025
Completion date
December 30, 2028
Enrollment
560 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer